SEC Schedule TO Tender Offer Filings: 2026 Investor Guide to Reading Hostile Takeovers and Buyout Bids

SEC Schedule TO Tender Offer Filings: 2026 Investor Guide to Reading Hostile Takeovers and Buyout Bids

When I was building FinanceTrackDaily on top of the SEC EDGAR API, the filing type that surprised me most was not the famous 10-K or 8-K. It was Schedule TO β€” the form an acquirer files the moment a tender offer goes public. Every cash buyout, every hostile takeover bid, every "we will pay shareholders 35% above market" announcement leaves a paper trail in EDGAR within minutes. After processing thousands of filings to feed FinanceTrackDaily's aggregator, I came to see Schedule TO as one of the most underrated documents on EDGAR for ordinary shareholders.

This guide explains what a Schedule TO is, what shows up inside it, how it interacts with Schedule 14D-9 (the target company's response), and how to actually pull these filings from EDGAR. It is written from the perspective of an engineer who reads these things at the API level, not from the perspective of a securities lawyer or financial advisor. It is meant to help you understand the disclosure framework so you can read primary sources for yourself.

Disclaimer: This article is for informational purposes only and is not financial, investment, legal, or tax advice. The author is a software engineer building a SEC EDGAR aggregator, not a registered investment advisor, broker-dealer, CFA, or CFP. Tender offer participation, M&A arbitrage, and securities trading involve significant risk including total loss of capital. Consult a licensed financial advisor and your own attorney before acting on any tender offer. Citations to SEC and FINRA rules reflect publicly available regulations as of 2026 and may change.

Two business professionals signing a corporate acquisition agreement
A friendly tender offer typically attaches an Agreement and Plan of Merger as an exhibit; a hostile one does not. Photo: Pexels.

What a tender offer actually is

A tender offer is a public proposal by one party β€” usually an acquiring company, a private equity buyer, or occasionally an activist β€” to buy shares directly from existing shareholders at a stated price, within a stated window. Instead of negotiating quietly with the board, the bidder makes the offer public and lets shareholders decide whether to "tender" (sell) their shares.

The U.S. legal framework for tender offers is built on the Williams Act of 1968, which amended the Securities Exchange Act of 1934. The Williams Act created Sections 14(d) and 14(e) of the Exchange Act, which govern how tender offers must be disclosed and conducted. These rules exist to protect shareholders from being stampeded into selling without information. The full text of these provisions is published by the SEC at sec.gov.

When a bidder commences a tender offer for more than 5% of a class of equity securities registered under Section 12 of the Exchange Act, the bidder is required to file Schedule TO with the SEC. The filing requirement comes from Rule 14d-100 (the form itself) and the broader Rule 14d-3 (when filing is required). The SEC publishes these rules under 17 CFR Part 240.

Where Schedule TO sits in the filing universe

Schedule TO is one of a small family of related filings:

  • Schedule TO-T: Filed by a third-party bidder (an outside acquirer).
  • Schedule TO-I: Filed by the issuer itself when conducting an issuer tender offer (a buyback structured as a tender, not an open-market repurchase).
  • Schedule TO-C: A "communication" filing made before the formal commencement of a tender offer, used when the bidder makes a written communication that could be considered a pre-commencement of the offer.
  • Schedule 14D-9: Filed by the target company in response to a third-party tender offer. The target's board uses 14D-9 to recommend, oppose, or remain neutral on the bid.
  • Schedule 13E-3: Filed when the tender offer is part of a "going-private" transaction.
  • Schedule 13E-4F: Used by certain Canadian issuer tender offers under the Multijurisdictional Disclosure System.

When you watch EDGAR for M&A activity, you typically see Schedule TO-T appear first, followed within ten business days by the target's Schedule 14D-9. That ten-business-day window is set by Rule 14e-2, which requires the target's board to publish a position on the offer.

Why Schedule TO matters for ordinary shareholders

For shareholders of the target company, Schedule TO is the document that contains the actual offer terms. Press releases summarize. Schedule TO is the binding document. It tells you:

  • The exact price per share being offered, in cash, stock, or a mix.
  • The total number of shares being sought and the percentage that represents.
  • The expiration date of the offer.
  • Conditions to the offer β€” including minimum tender conditions, regulatory approvals required, and material adverse change clauses.
  • The identity of the bidder and its sources of financing.
  • Any agreements with the target's board, management, or major shareholders.
  • The plans for the target after the tender offer succeeds, including delisting, board changes, and integration.

If you hold shares in a company that becomes the target of a tender offer, the Schedule TO and the corresponding 14D-9 are the two documents that should drive your decision about whether to tender, hold, or sell into the open market. From an engineering standpoint, when I built ingestion logic for these filings on FinanceTrackDaily, the structured items from Schedule TO are what surface in the M&A feed β€” they are the canonical record.

The structure of Schedule TO under Rule 14d-100

Rule 14d-100 lays out exactly what items a Schedule TO filing must contain. The form is a cover schedule that incorporates by reference disclosures from a longer "offer to purchase" document filed as an exhibit. The cover schedule itself is short, but the items it covers are critical:

  1. Item 1 β€” Summary Term Sheet. Plain-English summary of the offer. The SEC requires this in language a non-lawyer can read.
  2. Item 2 β€” Subject Company Information. Identifies the target, the class of securities being sought, and recent trading prices.
  3. Item 3 β€” Identity and Background of Filing Person. Identifies the bidder, its officers and directors, and any criminal or regulatory proceedings against them in the past five years.
  4. Item 4 β€” Terms of the Transaction. The price, number of shares, type of consideration, expiration date, withdrawal rights, and proration if oversubscribed.
  5. Item 5 β€” Past Contacts, Transactions, Negotiations, and Agreements. Any prior contact between the bidder and the target's board.
  6. Item 6 β€” Purposes of the Transaction and Plans or Proposals. Why the bidder is making the offer and what it plans to do with the company after.
  7. Item 7 β€” Source and Amount of Funds. Where the money is coming from. For a financed deal, this includes details of debt commitments and the lenders.
  8. Item 8 β€” Interest in Securities of the Subject Company. Any shares of the target already owned by the bidder or its affiliates.
  9. Item 9 β€” Persons/Assets, Retained, Employed, Compensated, or Used. Financial advisors, legal counsel, and information agents engaged by the bidder.
  10. Item 10 β€” Financial Statements. Required when the bidder is offering securities or the bidder's financial condition is material.
  11. Item 11 β€” Additional Information. Including regulatory approvals (such as Hart-Scott-Rodino antitrust review) and any litigation related to the offer.
  12. Item 12 β€” Exhibits. This is where the actual offer to purchase, the letter of transmittal, and the merger agreement (if any) are attached.
  13. Item 13 β€” Information Required by Schedule 13E-3. Only required for going-private transactions.

The cover schedule is typically a few pages. The exhibit pile β€” the offer to purchase, the letter of transmittal, the press release, and any related agreements β€” can run hundreds of pages. From an engineering perspective, parsing a Schedule TO means walking the exhibit list and pulling the offer to purchase document, which is where the substantive disclosure lives.

The mechanics: timing rules every shareholder should know

The Williams Act and the SEC's tender offer rules impose a strict timetable:

  • Minimum offer period. Under Rule 14e-1(a), a tender offer must remain open for at least 20 business days from the date it is first published or sent to security holders.
  • Extension on price or share-count change. Under Rule 14e-1(b), if the bidder increases or decreases the price, or changes the percentage of shares sought, the offer must remain open for at least 10 additional business days from the date of the change.
  • Withdrawal rights. Under Section 14(d)(5), shareholders who tender shares can withdraw them at any time during the offer period. Withdrawal rights are a non-negotiable shareholder protection.
  • Proration. If the offer is for less than all outstanding shares and is oversubscribed, the bidder must accept tendered shares pro rata under Rule 14d-8.
  • Best price rule. Under Rule 14d-10, all shareholders must receive the same price. If the bidder raises the price during the offer, every tendering shareholder gets the higher price.
  • Subsequent offering period. Under Rule 14d-11, the bidder may offer a "subsequent offering period" of at least three business days after the initial expiration to mop up untendered shares β€” but during this period there are no withdrawal rights.

These timing rules are the reason tender offers run on a predictable cadence. Once you have read enough of them, you start to recognize the pattern in the EDGAR feed: Schedule TO-T on day zero, 14D-9 within ten business days, amendments through the 20-business-day minimum, and then either expiration, extension, or completion.

Reading Schedule TO on EDGAR

EDGAR is the SEC's filing system, available at sec.gov/edgar. To find tender offer filings:

  1. Go to EDGAR Full-Text Search at efts.sec.gov/LATEST/search-index.
  2. Filter by form type "SC TO-T" for third-party tender offers, "SC TO-I" for issuer self-tenders, or "SC 14D9" for target responses.
  3. Each filing index page lists the exhibits. The exhibit named something like "Offer to Purchase" or labeled "EX-99.(a)(1)(A)" is the actual disclosure document.

Programmatically, EDGAR exposes a structured submissions JSON for each filer at data.sec.gov/submissions/CIK{cik}.json. From an engineering perspective, the workflow that powers FinanceTrackDaily's M&A ingestion is straightforward:

  • Subscribe to EDGAR's RSS feed for new SC TO-T and SC TO-I filings.
  • Pull the filing index to enumerate exhibits.
  • Extract the offer to purchase document, which is usually HTML or text.
  • Parse out structured fields: bidder name, target name, price per share, expiration date, conditions list.
  • Cross-reference the target ticker with the open-market price to compute the offer premium.

The premium calculation is where a lot of human attention concentrates. When the offer price is, say, $42 and the prior-day closing price was $30, the press release will say "40% premium." The EDGAR filing is what lets you confirm the exact price and verify it has not been quietly amended downward.

The target's response: Schedule 14D-9

Within ten business days of the Schedule TO being filed and disseminated, the target company's board must publish its position on the offer in a Schedule 14D-9. The 14D-9 must take one of four positions:

  1. Recommend acceptance of the offer.
  2. Recommend rejection of the offer.
  3. Express no opinion and remain neutral.
  4. State that it is unable to take a position.

Whichever position the board takes, it must explain its reasoning, disclose any conflicts of interest, summarize the financial advisor's fairness opinion (if any), and disclose any material agreements between the board and the bidder. The 14D-9 is filed under Rule 14d-9 and uses Form 14D-9.

For shareholders, the 14D-9 is at least as important as the Schedule TO. It is where the target's board commits, in writing, to a position that will be scrutinized by litigation if the deal goes wrong. When I ingest these on the engineering side, the 14D-9 recommendation is one of the structured fields I extract β€” it matters that much.

Friendly versus hostile

The popular distinction between "friendly" and "hostile" tender offers turns largely on what the 14D-9 says:

  • Friendly tender offer. The bidder and the target board have negotiated a merger agreement. The Schedule TO is filed pursuant to that agreement. The 14D-9 recommends acceptance. The deal usually closes if the minimum tender condition is met.
  • Hostile tender offer. The bidder bypasses the board and takes the offer directly to shareholders. The 14D-9 typically recommends rejection. The target's board may simultaneously deploy defensive tactics β€” a poison pill (shareholder rights plan), a white knight (alternative friendly bidder), a Pac-Man defense (counter-tender), or staggered board provisions.

You can usually tell from the EDGAR exhibits which kind of deal you are looking at. A friendly Schedule TO will reference and attach an Agreement and Plan of Merger as an exhibit. A hostile Schedule TO will not, and the target's 14D-9 will read accordingly.

Why Schedule TO is filed instead of just buying on the open market

A potential acquirer that wants to buy a controlling stake has several options under U.S. securities law:

  • Open-market accumulation, subject to Schedule 13D filing within 10 days once the buyer crosses 5%.
  • Negotiated private purchases from large blockholders.
  • A merger agreement followed by a shareholder vote.
  • A tender offer governed by Section 14(d) and Schedule TO.

Tender offers are chosen when the bidder wants speed and certainty. A merger agreement requires a target shareholder vote, which can take months and is subject to a target board that can negotiate. A tender offer can be commenced unilaterally and consummated in as little as 20 business days if the minimum tender condition is met. For private equity buyers and strategic acquirers facing a competitive deadline, that timing matters.

The downside of the tender offer route, from the bidder's perspective, is the regulatory disclosure burden β€” the very disclosures that make Schedule TO valuable for shareholders. The Williams Act, in essence, traded "you can move fast" for "you have to tell everyone what you're doing in detail."

Common conditions that decide whether a tender offer closes

Item 4 of Schedule TO and the offer to purchase exhibit lay out the conditions to the offer. The most common ones, in roughly the order they tend to appear in the filings I have processed:

  • Minimum tender condition. Usually that a majority or supermajority of shares (often two-thirds for Delaware corporations seeking a short-form merger) be tendered and not withdrawn.
  • HSR antitrust clearance. Hart-Scott-Rodino Act notification and the expiration of the waiting period.
  • Foreign regulatory clearances. Common for cross-border deals.
  • Material adverse effect (MAE) condition. A clause allowing the bidder to walk if a material adverse change occurs at the target before closing.
  • No litigation condition. No injunction blocking the offer.
  • Financing condition. Less common in modern deals β€” buyers increasingly arrange committed financing before commencing the offer to make the bid more credible.
  • Regulatory licensing. Industry-specific approvals such as FCC, FERC, or state insurance regulator approval.

Each condition is a real-world risk to the deal closing at the offered price. Reading them carefully is what separates "I'll just tender and hope" from understanding the actual probability that the deal closes.

Engineering perspective: what aggregating these filings teaches you

Building the ingestion pipeline for tender offers on FinanceTrackDaily revealed several things about this corner of EDGAR that I did not expect when I started:

  • Filing volume is bursty. Tender offer filings cluster around macroeconomic conditions. In months when financing is cheap and equity markets are volatile, the count of new SC TO-T filings can be several times the average. In tighter conditions, weeks can pass with none.
  • Amendments dominate. A typical tender offer generates one initial Schedule TO and then a long tail of Schedule TO/A amendments β€” for price increases, deadline extensions, additional disclosure, or litigation responses. From an engineering standpoint, you cannot just ingest the first filing and stop.
  • Issuer tender offers are different in character. Schedule TO-I filings, when a company tenders for its own shares, often look more like a structured buyback than a takeover. The "Dutch auction" tender offer is a common variant where the company sets a price range and lets shareholders specify the price at which they will tender.
  • The structured data layer is thin. Unlike 10-K filings, which now use XBRL extensively, Schedule TO disclosures are mostly free-text inside HTML exhibits. Reliable extraction requires careful parsing per-filing. This is the main engineering challenge in building any tender offer aggregator.
  • The 8-K cross-link is critical. Both the bidder and the target file 8-Ks announcing the deal contemporaneously with the Schedule TO. Linking the 8-K to the Schedule TO inside the data model is what lets you build a coherent timeline.

These observations are the kind of thing that emerges only after you have read the filings programmatically at scale. They are part of why I think building a SEC aggregator has been the most useful way for me, as an engineer, to learn how the U.S. capital markets actually disclose information.

Common mistakes I see in how people read Schedule TO

A few patterns repeat themselves in how non-specialists react to tender offer announcements:

  • Treating the press release as the filing. Press releases are marketing. Schedule TO and the offer to purchase exhibit are the binding documents. They sometimes differ on the conditions in subtle ways.
  • Ignoring the conditions list. A 35% premium offer that depends on antitrust clearance in three jurisdictions is not the same as one that is fully financed and condition-light.
  • Missing the proration mechanics. In partial tender offers, oversubscription leads to pro rata acceptance. You may tender 100 shares and have only 60 accepted.
  • Forgetting withdrawal rights. Tendering is reversible during the offer period. There is no need to commit on day one.
  • Assuming the target's board recommendation is dispositive. It is heavily weighted, but it is the board's view, not necessarily the only reasonable view. Read the 14D-9's reasoning, not just the headline.

Reading these documents takes time, but they are written for shareholders to read, by SEC mandate. The plain-English summary term sheet at the front of every offer to purchase exists exactly so non-specialists can engage with the offer.

Bringing it together

Schedule TO is the SEC filing that makes American tender offers transparent. It is the document that lets a retail shareholder, sitting at home with a brokerage account, read the same legally binding disclosure that a sophisticated arbitrage desk reads. From an engineering perspective, Schedule TO is one of the most rewarding form types to ingest β€” every filing represents a real corporate event with a clear timeline, a clear price, and a clear set of shareholder choices.

If you ever own shares in a company that becomes the target of a tender offer, the workflow I would suggest is: read the Schedule TO summary term sheet first, then the conditions in Item 4, then the target's 14D-9 recommendation and reasoning. Cross-reference the EDGAR filing with your broker's tender offer notice. And remember that withdrawal rights run all the way through the offer period β€” you have time to think.

For ongoing reading, the SEC's Office of Mergers and Acquisitions publishes interpretive guidance on tender offer rules at sec.gov/divisions/corpfin. The Investor.gov pages on tender offers provide plain-language explanations. These primary sources will always be more reliable than secondary commentary, including this article.

Final reminder: This guide is educational. It explains how Schedule TO and Schedule 14D-9 filings work and how an engineer building a SEC aggregator approaches them. It is not advice about whether to tender any specific shares, accept any specific offer, or trade around any specific deal. Tender offers can fail. Premiums can be illusory if conditions are not met. Consult a licensed financial advisor and your own attorney before acting on any tender offer affecting securities you own.

Found this helpful?

Subscribe to our newsletter for more in-depth reviews and comparisons delivered to your inbox.

Related Articles